Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene, ENSG00000243981, is annotated as a pseudogene related to the FAM182A gene family[1]. Pseudogenes are stretch of DNA that resemble functional genes but usually lack the ability to encode proteins due to disabling mutations, such as premature stop codons or frameshifts[4]. They may modulate gene expression at the RNA level by acting as decoys for microRNAs or generating regulatory RNA transcripts, but they are not known to serve as functional receptors, enzymes, or direct drug targets[2][3][4]. There is no evidence that this specific pseudogene encodes a receptor or is utilized in therapy or diagnostics. In summary, ENSG00000243981 is not a true molecular target but a pseudogene, included in reference databases mostly for annotation and sequence similarity studies[1][4].
None reported (No known mechanism of action for drugs targeting this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of family with sequence similarity 182, member A (FAM182A) (ENSG00000243981).